161 related articles for article (PubMed ID: 31222805)
1. Kaposi sarcoma in Southern Finland (2006-2018).
Kluger N; Blomqvist C; Kivelä P
Int J Dermatol; 2019 Nov; 58(11):1258-1263. PubMed ID: 31222805
[TBL] [Abstract][Full Text] [Related]
2. One hundred and five Kaposi sarcoma patients: a clinical study in Xinjiang, Northwest of China.
Wu XJ; Pu XM; Kang XJ; Halifu Y; An CX; Zhang DZ; Yakeya B; Mijit J
J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1545-52. PubMed ID: 25350316
[TBL] [Abstract][Full Text] [Related]
3. Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin.
Martín-Carbonero L; Palacios R; Valencia E; Saballs P; Sirera G; Santos I; Baldobí F; Alegre M; Goyenechea A; Pedreira J; González del Castillo J; Martínez-Lacasa J; Ocampo A; Alsina M; Santos J; Podzamczer D; González-Lahoz J;
Clin Infect Dis; 2008 Aug; 47(3):410-7. PubMed ID: 18582203
[TBL] [Abstract][Full Text] [Related]
4. Epidemiological and Clinical Patterns of Kaposi Sarcoma: A 16-Year Retrospective Cross-Sectional Study from Yaoundé, Cameroon.
Tounouga DN; Kouotou EA; Nansseu JR; Zoung-Kanyi Bissek AC
Dermatology; 2018; 234(5-6):198-204. PubMed ID: 30205412
[TBL] [Abstract][Full Text] [Related]
5. [Profile of Kaposi sarcoma patients in the competence network HIV/AIDS].
Klingenberg RE; Esser S; Brockmeyer NH; Michalik C; Skaletz-Rorowski A; Potthoff A;
Hautarzt; 2018 Feb; 69(2):143-148. PubMed ID: 29101417
[TBL] [Abstract][Full Text] [Related]
6. Histological evidence for the cardiac safety of high-dose pegylated liposomal doxorubicin in a patient with HIV-associated Kaposi sarcoma: a case report and literature review.
Ishihara A; Hatakeyama S; Suzuki J; Amano Y; Sasahara T; Toshima M; Morisawa Y
BMC Infect Dis; 2019 Oct; 19(1):848. PubMed ID: 31615436
[TBL] [Abstract][Full Text] [Related]
7. Evolution of Kaposi sarcoma in the past 30 years in a tertiary hospital of the European Mediterranean basin.
Marcoval J; Bonfill-Ortí M; Martínez-Molina L; Valentí-Medina F; Penín RM; Servitje O
Clin Exp Dermatol; 2019 Jan; 44(1):32-39. PubMed ID: 29934954
[TBL] [Abstract][Full Text] [Related]
8. Change in Pattern of Secondary Cancers After Kaposi Sarcoma in the Era of Antiretroviral Therapy.
Mukhtar F; Ilozumba M; Utuama O; Cimenler O
JAMA Oncol; 2018 Jan; 4(1):48-53. PubMed ID: 28837714
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Kaposi's sarcoma in HIV-1 infected individuals with emphasis on resource poor settings.
Dedicoat M; Vaithilingum M; Newton R
Cochrane Database Syst Rev; 2003; (3):CD003256. PubMed ID: 12917957
[TBL] [Abstract][Full Text] [Related]
10. Kaposi Sarcoma Updates.
Etemad SA; Dewan AK
Dermatol Clin; 2019 Oct; 37(4):505-517. PubMed ID: 31466590
[TBL] [Abstract][Full Text] [Related]
11. Kaposi sarcoma: no longer an AIDS-defining illness? A retrospective study of Kaposi sarcoma cases with CD4 counts above 300/mm³ at presentation.
Daly ML; Fogo A; McDonald C; Morris-Jones R
Clin Exp Dermatol; 2014 Jan; 39(1):7-12. PubMed ID: 23691969
[TBL] [Abstract][Full Text] [Related]
12. Skin nodules in a young patient with HIV/AIDS.
Hashmi H; Alexander JS
BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31537597
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma.
Cooley T; Henry D; Tonda M; Sun S; O'Connell M; Rackoff W
Oncologist; 2007 Jan; 12(1):114-23. PubMed ID: 17227906
[TBL] [Abstract][Full Text] [Related]
14. Kaposi's sarcoma: a reevaluation.
Orfanos CE; Husak R; Wölfer U; Garbe C
Recent Results Cancer Res; 1995; 139():275-96. PubMed ID: 7541146
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of an HIV-positive patient with unmasking Kaposi's sarcoma immune reconstitution inflammatory syndrome.
Speicher DJ; Sehu MM; Johnson NW; Shaw DR
J Clin Virol; 2013 Jul; 57(3):282-5. PubMed ID: 23578530
[TBL] [Abstract][Full Text] [Related]
16. Variants of Kaposi's sarcoma in Southern Africa. A retrospective analysis (1980-1992).
Stein ME; Lachter J; Spencer D; Margolius L; Bezwoda WR
Acta Oncol; 1996; 35(2):193-9. PubMed ID: 8639315
[TBL] [Abstract][Full Text] [Related]
17. Kaposi's sarcoma in a hospital setting in Lomé (Togo): a study of 93 cases.
Pitche PT; Kombate K; Owono F; Tchangai-Walla K
Int J Dermatol; 2007 Oct; 46 Suppl 1():42-4. PubMed ID: 17919207
[TBL] [Abstract][Full Text] [Related]
18. Treatment and outcome of AIDS-related Kaposi sarcoma in South Africa, Malawi and Zambia: an international comparison.
Rohner E; Kasaro M; Msadabwe-Chikuni SC; Stinson K; Mohamed Z; Tweya H; Egger M; Bohlius J
Pan Afr Med J; 2017; 28():261. PubMed ID: 29881504
[TBL] [Abstract][Full Text] [Related]
19. Kaposi's sarcoma in Nigeria.
Onunu AN; Okoduwa C; Eze EU; Adeyekun AA; Kubeyinje EP; Schwartz RA
Int J Dermatol; 2007 Mar; 46(3):264-7. PubMed ID: 17343581
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and associated risk factors for Kaposi's sarcoma among HIV-positive patients in a referral hospital in Northern Tanzania: a retrospective hospital-based study.
Semango GP; Charles RM; Swai CI; Mremi A; Amsi P; Sonda T; Shao ER; Mavura DR; Joosten LAB; Sauli E; Nyindo M
BMC Cancer; 2018 Dec; 18(1):1258. PubMed ID: 30558571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
